Author

Davide Oldrini

Observed institution: GlaxoSmithKline (Italy)
ORCID: 0000-0001-7827-6582
Observed ORCID: 0000-0001-7827-6582
OpenAlex ID: A5047296374
2017 · Filippo Carboni, Roberto Adamo, et al. · Proceedings of the National Academy of Sciences · 67
2017 · Nuria Martínez‐Sáez, Shuang Sun, et al. · Angewandte Chemie International Edition · 52
2020 · Davide Oldrini, Linda del Bino, et al. · Chemistry - A European Journal · 24
2016 · Timm Fiebig, Maria Rosaria Romano, et al. · npj Vaccines · 24
2021 · Vanessa Arato, Davide Oldrini, et al. · Microorganisms · 10
2023 · Davide Oldrini, Roberta Di Benedetto, et al. · Vaccines · 8
2021 · Gian Pietro Pietri, Marta Tontini, et al. · Frontiers in Molecular Biosciences · 8
2024 · Carlo Giannelli, Francesca Necchi, et al. · The AAPS Journal · 4
2025 · Luca Rovetini, Gianina Florentina Belciug, et al. · Methods and Protocols · 3
2020 · Davide Oldrini, Linda del Bino, et al. · Chemistry - A European Journal · 3
2026 · Valentina Monaci, Davide Oldrini, et al. · ACS Applied Materials & Interfaces
Works count: 29
Citation count: 491
H-index: 14
I10-index: 17
Year
Topic
Type